Difficulty: Medium
Average Score: 80%
Practice
Mechanism of action of sirolimus (rapamycin) is:
Correct answer
B
Rationale
The correct answer is B) Modulation of CD3 receptor from the cell surface. Sirolimus, also known as rapamycin, is an immunosuppressant medication that exerts its action by binding to a protein called FK-binding protein 12 (FKBP-12). This complex then binds to and inhibits the mammalian target of rapamycin (mTOR), which plays a crucial role in T cell activation and proliferation. By modulating the CD3 receptor from the cell surface, sirolimus interferes with the signal transduction pathway involved in T cell activation, thereby suppressing the immune response.
Option A) Anti-idiotype antibodies against autoantibodies is incorrect because it describes a mechanism related to immunotherapy for certain autoimmune diseases, not the mechanism of action of sirolimus.
Option C) Inhibits calcineurin is incorrect because this mechanism is associated with calcineurin inhibitors like cyclosporine and tacrolimus, not sirolimus.
Option D) ADCC towards T lymphocytes is incorrect because it refers to antibody-dependent cell-mediated cytotoxicity, a process involving the destruction of target cells by certain immune cells, which is not how sirolimus works.
In an educational context, understanding the mechanism of action of pharmacological agents like sirolimus is essential for healthcare professionals, especially those in pharmacology and therapeutics. This knowledge helps in selecting the appropriate medication for a specific condition, predicting potential drug interactions, and understanding the potential side effects and monitoring parameters associated with the drug. It also aids in promoting safe and effective medication use in patients across different age groups, emphasizing the importance of pharmacology across the lifespan.
Option A) Anti-idiotype antibodies against autoantibodies is incorrect because it describes a mechanism related to immunotherapy for certain autoimmune diseases, not the mechanism of action of sirolimus.
Option C) Inhibits calcineurin is incorrect because this mechanism is associated with calcineurin inhibitors like cyclosporine and tacrolimus, not sirolimus.
Option D) ADCC towards T lymphocytes is incorrect because it refers to antibody-dependent cell-mediated cytotoxicity, a process involving the destruction of target cells by certain immune cells, which is not how sirolimus works.
In an educational context, understanding the mechanism of action of pharmacological agents like sirolimus is essential for healthcare professionals, especially those in pharmacology and therapeutics. This knowledge helps in selecting the appropriate medication for a specific condition, predicting potential drug interactions, and understanding the potential side effects and monitoring parameters associated with the drug. It also aids in promoting safe and effective medication use in patients across different age groups, emphasizing the importance of pharmacology across the lifespan.